Skip to main content

SH Kang

First name:
SH
Last name:
Kang
Kang, S., Cho, H., Shim, G., Lee, S., Kim, S., Choi, H., … Koh, Y. (1969). Cationic Liposomal Co-delivery of Small Interfering RNA and a MEK Inhibitor for Enhanced Anticancer Efficacy. Pharmaceutical Research. https://doi.org/10.1007/s11095-011-0569-4 (Original work published)
Jang, N., Kwon, H., Park, M., Kang, S., & Bae, Y. (2018). Prognostic Value of Tumor-Infiltrating Lymphocyte Density Assessed Using a Standardized Method Based on Molecular Subtypes and Adjuvant Chemotherapy in Invasive Breast Cancer. Annals of Surgical Oncology. https://doi.org/10.1245/s10434-017-6332-2 (Original work published 2018)
Shin, S., Park, S., Kang, S., Kim, S., Kim, M., & Kim, D. Fluorine-19 Magnetic Resonance Imaging and Positron Emission Tomography of Tumor-Associated Macrophages and Tumor Metabolism. Contrast Media & Molecular Imaging, 2017, 4896310. https://doi.org/10.1155/2017/4896310 (Original work published 2017)